Public-registry site landscape for NCT05796765, “Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis”, a Knee Osteoarthritis study sponsored by MiMedx Group, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05796765 (registry record) |
| Study title | Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis |
| Official title | A Phase 2B, Prospective, Double-Blind, Randomized Controlled Trial of the Micronized DHACM Injectable Product Compared to Saline Placebo Injection for the Treatment of Osteoarthritis of the Knee |
| Sponsor | MiMedx Group, Inc. |
| Condition(s) | Knee Osteoarthritis |
| Phase | PHASE2 |
| Listed sites | 14 |
| Intervention(s) | Micronized DHACM 40 mg, Micronized DHACM 100 mg, Saline |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05796765.
Eichor generates a preliminary site-risk snapshot for NCT05796765 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
